Connect Biopharma Holdings (CNTB) Assets (2020 - 2026)

Connect Biopharma Holdings has disclosed Assets across 7 years of filings, most recently posting $43.5 million for Q2 2026.

• In Q2 2026, Assets fell 47.45% year-over-year to $43.5 million; the TTM figure through Jun 2026 stood at $43.5 million (down 47.45% YoY), while the FY2025 annual figure was $56.1 million, down 44.64% from the prior year.
• Assets came in at $43.5 million for Q2 2026 at Connect Biopharma Holdings, down from $60.1 million in the prior quarter.
• In the past five years, Assets ranged from a high of $234.7 million in Q2 2022 to a low of $43.5 million in Q2 2026.
• Average Assets over 5 years is $108.4 million, with a median of $97.0 million recorded in 2024.
• Year-over-year, Assets slipped 16.32% in 2024 and sank 47.45% in 2026.
• Over 5 years, Assets stood at $170.4 million in 2022, then decreased by 25.25% to $127.4 million in 2023, then decreased by 20.48% to $101.3 million in 2024, then sank by 44.64% to $56.1 million in 2025, then dropped by 22.48% to $43.5 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $43.5 million in Q2 2026, $60.1 million in Q1 2026, and $56.1 million in Q4 2025.